| 2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid |
2,5-双(2,2,2-三氟乙氧基)苯甲酸 |
35480-52-5 |
| Oxobutanedioic acid |
草酰乙酸 |
328-42-7 |
| 1-Fluoronaphthalene |
1-氟萘 |
321-38-0 |
| 1-(4-Chlorobenzhydryl)piperazine |
1-(4-氯二苯甲基)哌嗪 |
303-26-4 |
| N-Methyl-4-chloropyridine-2-carboxamide |
N-甲基-4-氯-2-吡啶甲酰胺 |
220000-87-3 |
| Atorvastatin Impurity 28 |
2,2-二氯-1-(4-氟苯基)-2-苯基乙酮 |
1403667-07-1 |
| 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)- |
(1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-74-2 |
| ledipasvir interMediate |
(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 |
1256387-87-7 |
| (R)-3-Methyl-1-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)butan-1-aMine hydrochloride |
(R)-(1-氨基-3-甲基丁基)硼酸频哪醇酯盐酸盐 |
1243174-57-3 |
| WAS-18 |
双(4 - 磺丁基)醚二钠 |
183278-30-0 |
| 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro- |
N-(3-氯-4-氟苯基)-7-氟-6-硝基-4-喹唑啉胺 |
162012-67-1 |
| (1R,3R)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLIC ACID, 1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPH ENYL), METHYL ESTER, HYDROCHLORIDE |
顺式-(1R,3R)-1,2,3,4-四氢-1-(3,4-亚甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯盐酸盐 |
171752-68-4 |
| Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate |
3-甲基-4-丁酰氨基-5-硝基苯甲酸甲酯 |
152628-01-8 |
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
利拉利汀母核 |
853029-57-9 |
| Sitagliptin Defuoro IMpurity 3 |
(3R)-3-[(叔丁氧羰基)氨基]-4-(2,4-二氟苯基)丁酸 |
851307-12-5 |
| 2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID |
5-甲基-2-(2H-1,2,3-三唑-2-基)苯甲酸 |
956317-36-5 |
| 1-[[2-(4-Chlorophenyl)ethyl]amino]-2-chloropropane |
1-[[2-(4-氯苯基)乙基]氨基]-2-氯丙烷盐酸盐 |
953789-37-2 |
| 2-Chloromethyl-3,4-dimethoxypyridine-N-oxide |
2-氯甲基-3,4-二甲氧基吡啶氮氧化物 |
953787-47-8 |
| BOC-(S)-3-AMINO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID |
(BETAS)-BETA-叔丁氧羰基氨基-2,4,5-三氟苯丁酸 |
922178-94-7 |
| Crisaborole |
克立硼罗 |
906673-24-3 |
